By proceeding, you agree to our Terms of Use and Privacy Policy.
Confidently Navigate Evolving European Regulatory Policies & Robustly Drive Data Collection to Support Drug Development & Reduce Barriers to Entry for Early Access Programmes to Bring Life Saving Treatments to Patients More Efficiently Europe currently has over 100 early and managed access, compassionate use, and named patient programmes running ac
Heed the advice of Expert Speakers like Magali Taiel from Gensight, Ramona Reichenbach from Novartis, Sara Radenovic from GSK, Shirle Zajac from Teva and more.
Organize supply & anticipate demand across multiple borders in sync with specific product & country requirements, meet data generation regulations in Europe.
The Pre-Conference Workshop Day will delve into ‘Agile Operational Planning for a Successful Pre-Approval Access Programme’ and more such themes.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Bionical Emas is a global Contract Research Organisation (CRO) business.
myTomorrows is a platform that helps patients and physicians discover and access treatments in development.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.